FIELD: chemistry.
SUBSTANCE: invention relates to pyrazolo [1,5-a][1,3,5] triazine and pyrazolo [1,5-a]pyrimidine derivatives and/or their pharmaceutically acceptable salts, use of these derivatives as pharmaceutically active agents. Present invention also relates to pharmaceutical compositions containing at least one of pyrazolo [1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives and/or pharmaceutically acceptable salts thereof.
EFFECT: prevention and/or treatment of cell proliferative diseases, inflammatory diseases, immunological diseases, cardiovascular diseases and infectious diseases.
10 cl, 6 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRAZOLOTRIAZINE AND/OR PYRAZOLOPYRIMIDINE DERIVATIVES AS A SELECTIVE CYCLIN-DEPENDENT KINASE INHIBITOR | 2019 |
|
RU2809779C2 |
| OXYSTEROLES AND METHODS OF USING THEM | 2016 |
|
RU2742333C2 |
| QUINOLINE DERIVATIVES AS INHIBITORS OF RECEPTOR TYROSINE KINASE Axl/Mer AND CSF1R | 2019 |
|
RU2812631C2 |
| NMDA RECEPTOR MODULATORS AND THEIR APPLICATION | 2012 |
|
RU2621049C2 |
| COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | 2015 |
|
RU2733756C2 |
| COMPOSITIONS SUITABLE FOR TREATING DISORDERS ASSOCIATED WITH KIT | 2014 |
|
RU2706235C2 |
| PYRIMIDINES, THEIR OPTIONS AND APPLICATION | 2017 |
|
RU2761439C2 |
| FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS | 2014 |
|
RU2704112C2 |
| ERBB/BTK INHIBITORS | 2019 |
|
RU2764069C1 |
| BICYCLIC LACTAMS AND METHODS FOR USE THEREOF | 2016 |
|
RU2716136C2 |
